Catalyst Pharmaceuticals Inc (CPRX) — Cash Flow Quality Index
Catalyst Pharmaceuticals Inc (CPRX) has a Cash Flow Quality Index of 0.93x as of March 2026. Operating cash flow of $59.59 Million is below net income of $63.73 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Catalyst Pharmaceuticals Inc (CPRX) cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Catalyst Pharmaceuticals Inc Cash Flow Quality Index (2019–2025)
Historical Cash Flow Quality Index for Catalyst Pharmaceuticals Inc across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how aggressively does Catalyst Pharmaceuticals Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Catalyst Pharmaceuticals Inc (2019–2025)
Year-by-year earnings quality comparison for Catalyst Pharmaceuticals Inc. For live market cap and the full company financial profile, see how much is Catalyst Pharmaceuticals Inc worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.97x | $208.67 Million | $214.33 Million | ▼ -33.5% |
| 2024 | 1.46x | $239.81 Million | $163.89 Million | ▼ -27.2% |
| 2023 | 2.01x | $143.60 Million | $71.41 Million | ▲ +44.0% |
| 2022 | 1.40x | $116.05 Million | $83.08 Million | ▼ -8.7% |
| 2021 | 1.53x | $60.37 Million | $39.48 Million | ▲ +154.6% |
| 2020 | 0.60x | $45.03 Million | $74.98 Million | ▼ -44.7% |
| 2019 | 1.09x | $34.61 Million | $31.88 Million | — |